OS Therapies Incorporated

OSTX
$1.89 (+ $0.08 + 4.42%)
Last updated: 2026-07-03 18:52 UTC
OSTX Metrics
Exchange
🇺🇸 NYSE XASE
NYSE Mkt LLCUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS68764Y2072
CUSIP68764Y207
Market Price1.89
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-0.79
Market Cap$53.5M
Book Value0.11
Price to Book13.945
BetaN/A
52w High7.0
52w Low1.12
Next Earnings DateN/A

OS Therapies Incorporated trades under ticker OSTX on NYSE as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US68764Y2072, CUSIP 68764Y207.

About the Company
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.
Price History